Cargando…
The prognostic roles of circulating ALDH1(+) tumor cell in the patients with non-small cell lung cancer
Circulating tumor cells can provide important diagnostic and prognostic information of the patients with non-small cell lung cancer (NSCLC). Aldehyde dehydrogenase 1 (ALDH1), a cancer stem cell marker, has been used in various tumors, including NSCLC. In the present study, we isolated the circulatin...
Autores principales: | Tian, Shuang, Xing, Ya-Nan, Xia, Pu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209584/ https://www.ncbi.nlm.nih.gov/pubmed/30305380 http://dx.doi.org/10.1042/BSR20180914 |
Ejemplares similares
-
Prognostic role of circulating tumor cells in patients with EGFR‐mutated or ALK‐rearranged non‐small cell lung cancer
por: Tong, Bing, et al.
Publicado: (2018) -
Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy
por: Tong, Bing, et al.
Publicado: (2017) -
Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer
por: You, Qinghua, et al.
Publicado: (2015) -
The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer
por: Kulasinghe, Arutha, et al.
Publicado: (2018) -
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
por: Obermayr, Eva, et al.
Publicado: (2021)